Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity

BACKGROUND AND AIMS: Epicardial adipose tissue (EAT), the visceral fat depot of the heart, is a modifiable cardio-metbolic risk factor and therapeutic target. Semaglutide and dulaglutide, glucagon-like peptide-1 (GLP-1) receptor agonists, are indicated for the treatment of type 2 diabetes mellitus (...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacobellis, Gianluca, Villasante Fricke, Alexandra C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069837/
https://www.ncbi.nlm.nih.gov/pubmed/32190806
http://dx.doi.org/10.1210/jendso/bvz042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069837/
https://www.ncbi.nlm.nih.gov/pubmed/32190806
http://dx.doi.org/10.1210/jendso/bvz042

Ejemplares similares